Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al
- PMID: 28056199
- DOI: 10.1200/JCO.2016.69.7961
Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al
Comment on
-
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.J Clin Oncol. 2016 Jun 10;34(17):2046-53. doi: 10.1200/JCO.2015.64.0821. Epub 2016 Feb 1. J Clin Oncol. 2016. PMID: 26834067 Free PMC article. Clinical Trial.
-
Delusional Beliefs and Hepatocellular Carcinoma.J Clin Oncol. 2017 Jan 10;35(2):256. doi: 10.1200/JCO.2016.67.2337. Epub 2016 Oct 23. J Clin Oncol. 2017. PMID: 28056192 No abstract available.
-
Chemoembolization or Bland Embolization for Hepatocellular Carcinoma: The Question Is Still Unanswered.J Clin Oncol. 2017 Jan 10;35(2):256-257. doi: 10.1200/JCO.2016.67.2915. Epub 2016 Oct 23. J Clin Oncol. 2017. PMID: 28056196 No abstract available.
-
Transarterial Embolization With or Without Chemotherapy: What Should Be the Indication for Patients With Hepatocellular Carcinoma?J Clin Oncol. 2017 Jan 10;35(2):257-258. doi: 10.1200/JCO.2016.68.4902. Epub 2016 Oct 23. J Clin Oncol. 2017. PMID: 28056197 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
